Novo Nordisk Stock Rises on Trial Results for Cagrilintide Obesity Treatment US$ 22.44 Min. order: 1 piece ★★★★★ 4.2 (199 reviews) Sold : Login>>
Novo Nordisk's CagriSema Falls Short in Head-to-Head Trial vs Zepbound | Bryce Platt, PharmD posted on the topic US$ 28.71 Min. order: 1 piece ★★★★★ 4.4 (127 reviews) Sold : Login>>
Novo Nordisk's Cagrilintide shows promising weight loss in REDEFINE-1 sub-analysis, unveiled at EASD 2025 US$ 21.85 Min. order: 1 piece ★★★★★ 4.9 (60 reviews) Sold : Login>>
Trial Scorecard: REDEFINE 1 and 2 US$ 29.35 Min. order: 1 piece ★★★★★ 4.3 (148 reviews) Sold : Login>>
New semaglutide and cagrilintide/semaglutide results US$ 23.95 Min. order: 1 piece ★★★★★ 5.0 (283 reviews) Sold : Login>>